Treatment and complications in elderly stage III colon cancer patients in the Netherlands

Author： Hoeben K. W. J.   van Steenbergen L. N.   van de Wouw A. J.   Rutten H. J.   van Spronsen D. J.   Janssen-Heijnen M. L. G.  

Publisher： Oxford University Press

ISSN： 0923-7534

Source： Annals of Oncology, Vol.24, Iss.4, 2013-04, pp. : 974-979

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Practical Outcome of Adjuvant FOLFOX4 Chemotherapy in Elderly Patients with Stage III Colon Cancer: Single-center Study in Korea

By Kim Ji-Yeon   Kim Yu Jung   Lee Keun-Wook   Lee Jong Seok   Kim Duck-Woo   Kang Sung-Bum   Lee Hye Seung   Jang Na Young   Kim Jae-Sung   Kim Jee Hyun  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 2, 2013-02 ,pp. : 132-138

Oxford University Press

Access to resources Recommend Favorite

Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients

By Bastiaannet E.  

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 801-807

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant chemotherapy in elderly patients (≥75 yr) completely resected for colon cancer stage III compared to younger patients: Toxicity and prognosis

By Jensen Søren   Vilmar Adam   Sørensen Jens  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 521-531

Humana Press, Inc

Access to resources Recommend Favorite

Adjuvant chemotherapy in stage III colon cancer: Guideline implementation, patterns of use and outcomes in daily practice in The Netherlands

By van Gils Chantal W. M.   Koopman Miriam   Mol Linda   Redekop William K.   Uyl-de Groot Carin A.   Punt Cornelis J. A.  

Acta Oncologica, Vol. 51, Iss. 1, 2012-01 ,pp. : 57-64

Informa Healthcare

Access to resources Recommend Favorite

Lung function changes and pulmonary complications in patients with stage III non-small cell lung cancer treated with gemcitabine/cisplatin as part of combined modality treatment

By Maas K.W.   van der Lee I.   Bolt K.   Zanen P.   Lammers J.W.J.   Schramel F.M.N.H.  

Lung Cancer, Vol. 41, Iss. 3, 2003-09 ,pp. : 345-351

Elsevier

Access to resources Recommend Favorite